Methods and devices for hormone replacement therapy
OwnerDavid Friend, Christine Mauck +1inventors
InventorsDavid Friend, Christine Mauck, Nadene Zack
Life of this patent
Estimating the term…
Abstract
The present invention is in the field of intravaginal rings, in particular segmented, ethylene-vinyl acetate (EVA) intravaginal rings, and their use treating, ameliorating, or preventing, vasomotor symptoms in perimenopause and/or menopausal women and for treating, ameliorating, or preventing vulvar and vaginal atrophy (VVA).
Claims27
A method for treating one or more symptoms of menopause in a subject, comprising intravaginally inserting an implantable drug delivery device to the subject, wherein the implantable drug delivery device comprises an estrogen and a progestin, and further wherein the implantable drug delivery device provides a baseline-adjusted steady state plasma estrogen concentration between about 15 pg/mL and about 50 pg/mL in the subject.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.